Short answer: Growth in the wellness economy can justify investigating a new service, but it cannot justify buying a wellness capsule on its own. The Global Wellness Institute (GWI) reported that global wellness spending reached $6.8 trillion in 2024 and forecast $9.8 trillion by 2029. Those figures combine many types of spending across 11 sectors. They are not US sales of capsules, a utilization forecast for a particular location, or evidence that one equipment model will earn a return.
GWI released the figures on 19 November 2025 in its announcement of the Global Wellness Economy Monitor 2025. It reported 7.9% global growth from 2023 to 2024 and identified wellness real estate and mental wellness as the fastest-growing sectors over 2019-2024. It said North America had the highest annual regional growth over the preceding five years at 7.9%. North America is a region, not the United States alone; none of these percentages measures demand for a capsule installation. The $9.8 trillion figure is a projection, not spending already observed in 2029.
Separate a broad market from a local purchase case
GWI’s United States country page describes the US as the world’s largest wellness economy and says its country report measures 11 sectors from 2019 through 2024. That is useful market context, but the categories span products, services, travel and technology. A buyer planning a capsule room needs a narrower answer: how many potential customers in the actual catchment area would book this particular experience at an acceptable price? Existing spa or salon customers, nearby competitors, available floor space and staff capacity matter more to this decision than a global total.
Before requesting a quote, define the intended service in plain language. Is the capsule a private relaxation session, a complementary feature in a larger wellness visit, or equipment to be sold to other businesses? Identify which claims the operator intends to make and which can be supported. Do not translate market spending on wellness into a medical or therapeutic claim about a device. Ask prospective customers what they would use, what would stop them and whether they would return. Record the questions and responses rather than turning a small informal sample into a claimed market statistic.
Build a testable operating model
Estimate the full cost of purchase, shipping, installation, electrical work, room preparation, training, cleaning, consumables, servicing and downtime. Then model bookings per day, session duration, reset time, staffing, price and repeat visits under several plausible scenarios. A useful question is the minimum sustained utilization needed to cover costs, not the largest forecast in an industry press release. Test the assumptions against local bookings or a small pilot before expanding. The results will vary by venue; GWI’s report does not provide a universal payback period for capsules.
Ask suppliers for the exact model’s dimensions, power requirements, installation conditions, operating instructions, maintenance plan and current documentation relevant to the destination market. Compare the delivered configuration with the quote. For a US site, discuss building, electrical, accessibility, advertising and any device-classification questions with qualified local advisers. A global economic report cannot establish that a particular capsule is approved for diagnosis or treatment, meets a particular standard, or is suitable for every guest.
TUOKE buyer perspective: Review the wellness-capsule category as a starting point, then request model-specific information and an operating-cost discussion. We do not treat broad wellness spending as proof of a buyer’s sales, a product’s health effects or a guaranteed investment return. This article is commercial planning context, not financial, legal or medical advice.
Sources
- Global Wellness Institute, Global Wellness Economy Monitor 2025 announcement, 19 November 2025; reviewed 7 October 2026.
- Global Wellness Institute, Wellness in the United States, undated live country page describing the 2019-2024 report period; reviewed 7 October 2026.